Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent Clp protease ATP-binding subunit ClpX (ClpX) is a vital molecular chaperone and ATPase belonging to the AAA+ family in Helicobacter pylori (UniProt: P56001). It functions as the regulatory component of the ClpXP proteolytic complex, where it identifies, unfolds, and translocates substrate proteins into the ClpP degradation chamber (PubMed: 21613457). In H. pylori, ClpX is essential for maintaining protein quality control and is specifically involved in regulating key virulence factors, including flagellar-mediated motility and urease activity (PubMed: 15937173). These factors are critical for the bacterium's survival and colonization in the acidic stomach environment. Because of its central role in bacterial physiology and pathogenesis, ClpX is an attractive target for novel antimicrobial strategies aimed at treating chronic H. pylori infections (PubMed: 30254014). While no drugs targeting ClpX are currently FDA-approved, research into small-molecule inhibitors that disrupt its ATPase activity or its interaction with ClpP is ongoing (PubMed: 25605321). Such inhibitors could potentially overcome the challenges of antibiotic resistance in H. pylori treatment.
Inhibition of ATPase activity or disruption of the ClpX-ClpP complex formation, leading to impaired protein degradation and bacterial cell death or reduced virulence (PubMed: 30254014).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent Clp protease ATP-binding subunit ClpX (ClpX) (ClpX).